Click on a title to open the PDF. You will need Adobe Acrobat Reader installed on your computer to view the PDF files. If you do not have Adobe Acrobat Reader, you can download it from
.
151
|
Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH,
and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled,
two-part crossover studies in healthy volunteers. |
| |
Houghton LA, Atkinson W, Whorwell PJ, Morris J, Murdoch RD, Cooper SM, Webber DM, Walls CM. |
Clin Ther. 2006;28:569-81. |
| 152 |
Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. |
| |
Jones H, Cooper P, Miller V, Brooks N, Whorwell PJ. |
Gut 2006;55:1403-8. |
| 153 |
FAQs: irritable bowel syndrome. |
| |
Whorwell PJ. |
Practitioner 2006;250:29-32. |
| 154 |
The growing case for an immunological component to irritable bowel syndrome. |
| |
Whorwell PJ. |
Clin Exp Allergy 2007;37(6):805-7. |
| 155 |
Guidelines on the irritable bowel syndrome: mechanisms and practical management. |
| |
Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L,
Hungin P, Jones R, Kumar D, Rubin G, Trudgill N,
Whorwell P. |
Gut 2007; 56 : 1770-98. |
156
|
Effect of a second-generation alpha2delta ligand (pregabalin) on visceral
sensation in hypersensitive patients with irritable bowel syndrome. |
| |
Houghton LA, Fell C, Whorwell PJ, Jones I,
Sudworth DP, Gale JD. |
Gut 2007; 56 : 1218-25. |
157
|
Sigmoid-colonic motility in health and irritable bowel syndrome:
a role for 5-hydroxytryptamine. |
| |
Houghton LA, Atkinson W, Lockhart S, Fell C,
Whorwell PJ, Keevil B. |
Neurogastroenterol Motil 2007; 19 : 724-31. |
158
|
Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory
function and compliance in healthy humans. |
| |
Houghton LA, Cremonini F, Camilleri M, Busciglio I,
Fell C, Cox V, Alpers DH, Dewit OE, Dukes GE,
Gray E, Lea R, Zinsmeister AR, Whorwell PJ. |
Neurogastroenterol Motil 2007; 19 : 732-43. |
| 159 |
Hypnotherapy for non-cardiac chest pain: long-term follow-up. |
| |
Miller V, Jones H, Whorwell PJ. |
Gut 2007; 56 : 1643. |
| 160 |
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. |
| |
Evans BW, Clark WK, Moore DJ, Whorwell PJ. |
Cochrane Database Syst Rev 2007;17: CD003960. |
| 161 |
Dietary aspects of irritable bowel syndrome (IBS). |
| |
Whorwell PJ. |
Digestive Health Matters 2007;16:6-7. |
162
|
Review article: abdominal bloating and distension in functional gastrointestinal disorders - epidemiology and exploration of possible mechanisms. |
| |
Agrawal A, Whorwell PJ. |
Aliment Pharmacol Ther 2008; 27 : 2-10. |
| 163 |
Bloating and distention in irritable bowel syndrome: the role of visceral sensation. |
| |
Agrawal A, Houghton LA, Lea R, Morris J,
Reilly B, Whorwell PJ. |
Gastroenterology 2008; 134 : 1882-9. |
164
|
Hypnotherapy for irritable bowel syndrome: the response
of colonic and noncolonic symptoms. |
| |
Whorwell PJ. |
J Psychosom Res 2008; 64 : 621-3. |
| 165 |
Irritable bowel syndrome: an approach to treating patients. |
| |
Whorwell PJ. |
Digestive Health Matters 2008;17:4-7. |
